ZA977151B - Mannose-6-phosphate composition and its use in treating fibrotic disorders - Google Patents

Mannose-6-phosphate composition and its use in treating fibrotic disorders

Info

Publication number: ZA977151B
Authority: ZA; South Africa
Prior art keywords: mannose; fibrotic disorders; phosphate composition; treating fibrotic; phosphate
Prior art date: 1996-08-12

Application number

ZA977151A

Other languages

English (en)

Inventor

Mark William James Ferguson

Original Assignee

British Tech Group

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-12

Filing date

1997-08-11

Publication date

1999-02-11

1997-08-11 Application filed by British Tech Group filed Critical British Tech Group

1999-02-11 Publication of ZA977151B publication Critical patent/ZA977151B/xx

Links

NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000003176 fibrotic effect Effects 0.000 title 1
239000000725 suspension Substances 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
238000010979 pH adjustment Methods 0.000 abstract 1
230000036573 scar formation Effects 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Inorganic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Materials For Medical Uses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA977151A 1996-08-12 1997-08-11 Mannose-6-phosphate composition and its use in treating fibrotic disorders ZA977151B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9616896.8A GB9616896D0 (en)	1996-08-12	1996-08-12	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ZA977151B true ZA977151B (en)	1999-02-11

Family

ID=10798358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA977151A ZA977151B (en)	1996-08-12	1997-08-11	Mannose-6-phosphate composition and its use in treating fibrotic disorders

Country Status (12)

Country	Link
EP (1)	EP0921806B1 (de)
JP (2)	JP4971534B2 (de)
AT (1)	ATE249225T1 (de)
AU (1)	AU721224B2 (de)
CA (1)	CA2261988C (de)
DE (1)	DE69724798T2 (de)
DK (1)	DK0921806T3 (de)
ES (1)	ES2206737T3 (de)
GB (1)	GB9616896D0 (de)
PT (1)	PT921806E (de)
WO (1)	WO1998006406A1 (de)
ZA (1)	ZA977151B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions
WO2004031379A1 (en) *	2002-10-01	2004-04-15	Unilever N.V.	Proteins having polysaccharidase activity
US9517023B2 (en)	2009-06-01	2016-12-13	Profusa, Inc.	Method and system for directing a localized biological response to an implant
GB0910078D0 (en)	2009-06-11	2009-07-22	Renovo Ltd	Uses of mannose-6-phosphate
GB0916333D0 (en)	2009-09-17	2009-10-28	Renovo Ltd	Improvement of tendon repair
US10010272B2 (en)	2010-05-27	2018-07-03	Profusa, Inc.	Tissue-integrating electronic apparatus
WO2012048150A1 (en)	2010-10-06	2012-04-12	Profusa, Inc.	Tissue-integrating sensors
WO2014158988A1 (en)	2013-03-14	2014-10-02	Profusa, Inc.	Method and device for correcting optical signals
US10219729B2 (en)	2013-06-06	2019-03-05	Profusa, Inc.	Apparatus and methods for detecting optical signals from implanted sensors
WO2018119400A1 (en)	2016-12-22	2018-06-28	Profusa, Inc.	System and single-channel luminescent sensor for and method of determining analyte value
GB201904469D0 (en) *	2019-03-29	2019-05-15	Givaudan Sa	Cosmetic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5244651A (en) *	1991-09-04	1993-09-14	Kao Corporation	Method of desensitizing hypersensitive dentin
GB9205800D0 (en) *	1992-03-17	1992-04-29	British Tech Group	Treatment of fibrotic disorders
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions

1996
- 1996-08-12 GB GBGB9616896.8A patent/GB9616896D0/en active Pending
1997
- 1997-07-31 DE DE69724798T patent/DE69724798T2/de not_active Expired - Lifetime
- 1997-07-31 DK DK97934624T patent/DK0921806T3/da active
- 1997-07-31 AT AT97934624T patent/ATE249225T1/de active
- 1997-07-31 JP JP50947298A patent/JP4971534B2/ja not_active Expired - Fee Related
- 1997-07-31 CA CA002261988A patent/CA2261988C/en not_active Expired - Fee Related
- 1997-07-31 AU AU37769/97A patent/AU721224B2/en not_active Ceased
- 1997-07-31 EP EP97934624A patent/EP0921806B1/de not_active Expired - Lifetime
- 1997-07-31 ES ES97934624T patent/ES2206737T3/es not_active Expired - Lifetime
- 1997-07-31 WO PCT/GB1997/002076 patent/WO1998006406A1/en not_active Ceased
- 1997-07-31 PT PT97934624T patent/PT921806E/pt unknown
- 1997-08-11 ZA ZA977151A patent/ZA977151B/xx unknown
2009
- 2009-05-29 JP JP2009129987A patent/JP2009221220A/ja active Pending

Also Published As

Publication number	Publication date
JP2000516603A (ja)	2000-12-12
JP4971534B2 (ja)	2012-07-11
ATE249225T1 (de)	2003-09-15
DE69724798T2 (de)	2004-07-15
CA2261988C (en)	2006-11-07
DK0921806T3 (da)	2003-12-08
CA2261988A1 (en)	1998-02-19
AU721224B2 (en)	2000-06-29
JP2009221220A (ja)	2009-10-01
AU3776997A (en)	1998-03-06
PT921806E (pt)	2003-12-31
WO1998006406A1 (en)	1998-02-19
EP0921806A1 (de)	1999-06-16
ES2206737T3 (es)	2004-05-16
DE69724798D1 (de)	2003-10-16
EP0921806B1 (de)	2003-09-10
GB9616896D0 (en)	1996-09-25

Similar Documents

Publication	Publication Date	Title
TW271452B (de)	1996-03-01
ZA977151B (en)	1999-02-11	Mannose-6-phosphate composition and its use in treating fibrotic disorders
EP0154447A3 (en)	1987-08-12	Compositions and method for improving wound healing
ATE207753T1 (de)	2001-11-15	Wundheilmittel
DE69929810D1 (de)	2006-04-20	Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
DE69013833D1 (de)	1994-12-08	Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
IL192078A0 (en)	2008-12-29	Recombinant ??-l-iduronidase,methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
UA8025A1 (uk)	1995-12-26	Спосіб отримання антибактеріального розчину
NZ506157A (en)	2003-02-28	Process for making a stable organosilanized colloidal silica suspension
PL328412A1 (en)	1999-01-18	Derivatives of benzamidine substituted with derivatives of amino acid and hydroxy acid as well as their application as antithrombotic agents
ATE257712T1 (de)	2004-01-15	Gesteigerte stimulation der erythropoesis
HK1049115A1 (zh)	2003-05-02	治療過敏性失調的成分和方法
PT862452E (pt)	2004-04-30	Formulacao de estabilizacao para o ngf
YU47100A (sh)	2002-11-15	Novi derivati dihidroksiheksanoinske kiseline
DE69535081D1 (de)	2006-08-03	Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
NZ332834A (en)	2000-01-28	Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
BR0009949A (pt)	2002-01-08	Método para reduzir unidades de formação de colÈnia de bactérias em levedura, e, levedura
DE69132050D1 (de)	2000-04-20	Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
MXPA01006011A (es)	2004-04-05	Composicion para tratamiento de quemaduras.
BR9915528A (pt)	2001-07-31	Processo para tornar hidrófobas as partìculas e seu uso em dispersões
EP0711175A4 (de)	1996-01-26	Lokal anwendbares präparat zur reepithelisierung bei andauernden epitheldefekten
DE69813549D1 (de)	2003-05-22	Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung
GB9425071D0 (en)	1995-02-08	Chondrocyte cell lines
HUP9802142A2 (hu)	1999-04-28	Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására
RU94021202A (ru)	1996-04-20	Силикатное рельсовое покрытие